E pluribus plurima: Multidimensional indices and clinical phenotypes in COPD

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Rossi, Andrea ^a   Zanardi, Erika ^a  

^a GENERAL HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AIR POLLUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LETTER; LIFESTYLE; PATHOPHYSIOLOGY; PHLEGMON; RISK FACTOR; SPIROMETRY; AIRWAY OBSTRUCTION; ARTICLE; BRONCHITIS; CHRONIC COUGH; EXERCISE TOLERANCE; LUNG INJURY; SMALL AIRWAY DISEASE; SMOKING; VITAL CAPACITY; HOSPITALIZATION; LUNG FUNCTION TEST; METHODOLOGY; MORTALITY; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICS; SURVIVAL; SURVIVAL RATE; UTILIZATION REVIEW;

DATA INTERPRETATION, STATISTICAL; HOSPITALIZATION; HUMANS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 81055131762     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-152     Document Type: Letter

References (45)

1. National Clinical guideline Centre Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010, London: National Clinical Guideline Centre, National Clinical guideline Centre., http://guidance.nice.org.uk/CG101/Guidance/pdf/English
2. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009, 374:733-743. 10.1016/S0140-6736(09)61303-9, 19716966.
3. GOLD Global Initiative for Chronic Obstruction Lung Disease. Global Strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease 2010, GOLD., http://www.goldcopd.com
4. Celli BR, MacNee W. Standard for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. 10.1183/09031936.04.00014304, 15219010.
5. Vestbo J, Rodriguez-Rosin R. GOLD and the fixed ratio. Eur Respir J 2011, 38:481-2. 10.1183/09031936.00042411, 21804170.
6. O'Donnell DE, Aron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Maltais F, Road J. Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease - 2003. Can Respir J 2003, 10(Suppl A):11A-33A.
7. Quanjer PH, Enright PL, Miller MR, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP, Jensen RL. The need to change the method for defining mild airway obstruction. Eur Respir J 2011, 37:720-722. 10.1183/09031936.00135110, 21357929.
8. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J, . on behalf of the Task Force Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995, 8:1398-1420. 10.1183/09031936.95.08081398, 7489808, on behalf of the Task Force.
9. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968. 10.1183/09031936.05.00035205, 16264058.
10. MacNee W. Clinic Practice Guidelines: more of the same?. Am J Respir Crit Care Med 2001, 184:492-494.
11. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, . UPLIFT Study Investigators A 4-year trial of triotropium in chronic obstructive pulmonary disease. N Engl L Med 2008, 359:1543-54. UPLIFT Study Investigators.
12. Washko GR, Fan VS, Ramsey SD, Mohseinifar Z, Martinez F, Make BJ, Sciurba FC, Criner GJ, Minai O, Decamp MM, Reilly JJ, . National Emphysema Treatment Trial Research Group The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exarcerbations. Am J Respir Crit Care Med 2008, 177:164-169. 2204077, 17962632, National Emphysema Treatment Trial Research Group.
13. Hogg JC, Chu F, Utokaparch S, Woods R, Elliot WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
14. Irving CG. Will the small airways rise again?. Am J Respir Crit Care Med 2011, 184:499-500. 10.1164/rccm.201107-1188ED, 21885632.
15. Reilly JJ, Silverman EK, Shapiro SD. COPD. Harrison's principles of internal medicine 2008, McGrowHill, NYC, NY, 17, 3215259, 22096754.
16. Casanova C, Cote C, De Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-Total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171:591-597.
17. Roussos C, Macklem PT. The respiratory muscles. N Eng J Med 1982, 307:786-97.
18. O'Donnel DE. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:180-184. 10.1513/pats.200508-093DO, 16565429.
19. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006, 119(Suppl 1):21-31.
20. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010, 362:217-27. 10.1056/NEJMoa0808836, 2887729, 20089972.
21. Siafakas NM. Preventing exacerbations of COPD - Advice from Hippocrates. N Engl J Med 2001, 356:753-4.
22. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA, . Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363:1128-1138. 10.1056/NEJMoa0909883, 20843247, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
23. Augusti A, Calverly PMA, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J, . Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122. 2944278, 20831787, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators.
24. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O'Connor GT, Benjamin EJ. Systemic inflammation and COPD. The Framingham Heart Study. Chest 2008, 133:19-25. 10.1378/chest.07-0058, 17908709.
25. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome?. Lancet 2007, 370:797-99. 10.1016/S0140-6736(07)61383-X, 17765529.
26. van Dijk WD, van den Bemt L, van den Haak-Rongen S, Bischoff E, van Weel C, Veen JCCM, Schermer TRJ. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res 2011,
27. Fletcher C, Peto R, Tinker C, Speizer FE. The Natural history of chronic bronchitis and emphysema. 1976, Oxford University Press. Oxford.
28. Fletcher C, Peto R. The Natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648. 10.1136/bmj.1.6077.1645, 1607732, 871704.
29. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, Jones PW, Mahler DA, Make B, Miravitlles M, Page CP, Palange P, Parr D, Pistolesi M, Rennard SI, Rutten-van Mölken MP, Stockley R, Sullivan SD, Wedzicha JA, Wouters EF, . on behalf of the American Thoracic Society/European Respiratory Society Task Force on outcomes of COPD Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008, 31:416-468. 10.1183/09031936.00099306, 18238951, on behalf of the American Thoracic Society/European Respiratory Society Task Force on outcomes of COPD.
30. Augusti A, Vestbo J. Current controversies and future perspectives in COPD. AJRCCM 2011,
31. Netter FH. Atlas of human anatomy. Pulmonary Chronic Obstructive Disease 1980, 4:148-149. Ciba Collection.
32. Tashkin DP. Frequent exacerbation of COPD a distinct phenotypes?. N Engl J Med 2010, 363:1183-4. 10.1056/NEJMe1008184, 20843256.
33. Parr DG. Patient phenotyping and early disease detection in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011, 8:338-349. 10.1513/pats.201101-014RM, 21816990.
34. Hurst JR. Exarcerbation phenotyping in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011, 184:625-626. 10.1164/rccm.201106-1136ED, 21920921.
35. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JAD, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR, . COPD Clinical Research Network Azithromycin for prevention of exacerbation of COPD. N Engl J Med 2011, 365:389-98. COPD Clinical Research Network.
36. Rupert CJ, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, Wedzicha JA, Price D, Hyland ME. Derivation and validation of Composite Index of severity in chronic obstructive pulmonary disease. The DOSE index. Am J Respir Crit Care Med 2009, 180:1189-95. 10.1164/rccm.200902-0271OC, 19797160.
37. Postma DS, Calverly P. Inhaled corticosteroids in COPD: a case in favor. Eur Resp J 2009, 34:10-12.
38. Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respi J 2009, 34:13-16.
39. Lapperre TS, Snoeck-Stroband JB, Gosman MME, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ, . Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2009, 151:517-27. Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.
40. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:418-424. 10.1164/rccm.200203-183OC, 12426229.
41. Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Sputum eosinophilia and short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax 2005, 60:193-198. 10.1136/thx.2004.032516, 1747331, 15741434.
42. Decreamer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP, . for the UPLIFT investigators Effect of tiotropium on outocomes in patients with moderate chronic obstructive pulmoanry disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trails. Lancet 2009, 374:1171-8. 10.1016/S0140-6736(09)61298-8, 19716598, for the UPLIFT investigators.
43. Celli B, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from TORCH study. Am J Respir Crit Care Med 2008, 178:332-338. 10.1164/rccm.200712-1869OC, 18511702.
44. Kohansal R, Martinez-Camblor P, Augusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009, 180:3-10. 10.1164/rccm.200901-0047OC, 19342411.
45. Renanrd SI, Vestbo J. Natural histories of chronic obstructive pulmoanry disease. Proc Am, Thorac Soc 2008, 8:878-883.